ginsenoside rh2 has been researched along with d-alpha tocopherol in 1 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (d-alpha tocopherol) | Trials (d-alpha tocopherol) | Recent Studies (post-2010) (d-alpha tocopherol) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 32,198 | 2,903 | 7,258 |
| Protein | Taxonomy | ginsenoside rh2 (IC50) | d-alpha tocopherol (IC50) |
|---|---|---|---|
| Glutathione S-transferase P | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, F; Kondo, R; Liu, J; Shimizu, K; Shiono, J; Yu, H; Zhang, C | 1 |
1 other study(ies) available for ginsenoside rh2 and d-alpha tocopherol
| Article | Year |
|---|---|
20(R)-ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity.
Topics: Animals; Cell Differentiation; Cell Line; Ginsenosides; Humans; Mice; Osteoclasts; Stereoisomerism | 2009 |